United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-822_8b088034-c702-4b88-b4e3-421aa9739ec8
- Product NDC
- 16571-822
- Form
- TABLET
- Composition / generic term
- loratadine
- Labeler
- Rising Pharmaceuticals, Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220310
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (16571-822-01) · 16571-822-01
- 30 TABLET in 1 BOTTLE (16571-822-03) · 16571-822-03
- 300 TABLET in 1 BOTTLE (16571-822-30) · 16571-822-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →